A model study directed towards the synthesis of the Annonaceous acetogenin cis-solamin (1) is reported. The key step in the synthesis involved the permanganate-promoted oxidative cyclisation of ethyl (E)-7-methylocta-2,6-dienoate (7) to afford a tetrahydrofuran diol 6. The remaining C 1 -C 13 portion of the target was introduced using an organocopper-mediated opening of epoxide 5, followed by a ruthenium-catalysed Alder−ene reaction. Significantly, no protecting groups were required during the assembly of the fragments.
Introduction
The Annonaceous acetogenins are natural products isolated from the plant family, Annonaceae (custard-apple family). They are derived from C32 or C34 fatty acids combined with a 2-propanol unit at C2 that typically forms part of a terminal α,β-unsaturated γ-lactone (butenolide). In addition, one or more 2,5-disubstituted tetrahydrofuran (THF) rings are often present in the hydrocarbon backbone, which may carry oxygen substituents or unsaturation along its length. Considerable interest has been shown in the Annonaceous acetogenins, largely due to their cytotoxicity both towards healthy cells, but particularly cancerous cells. 1, 2 Their mechanism of action involves ATP deprivation as a result of inhibition of the NADH: ubiquinone oxoreductase present in complex I of the mitochondrial electron transport system, and the ubiquinone-linked NADH oxidase that is active in plasma membranes of cancerous cells. 3 Other biological properties such as immunosuppressive, pesticidal, antiprotozoal, antifeedant, anthelmintic and antimicrobial activities have been reported, 1, [4] [5] [6] further fuelling interest in these natural products.
A substantial number of total syntheses of Annonaceous acetogenins have now been published, 1, 7 and some studies towards the synthesis of biologically active analogues have appeared. [8] [9] [10] Most of the synthetic work to date has focused on the preparation of compounds with trans-2,5-disubstituted THF rings, whereas the synthesis of the cis-isomers has been comparatively neglected.
Scheme 1.
Approach to cis-2,5-disubstituted THF-containing acetogenins employing a permanganate-promoted oxidative cyclisation.
The butenolide ring present in 2 would be prepared using a ruthenium-catalysed Alder−ene reaction developed by Trost. 19 Introduction of the required alkenyl chain would be carried out using an organocopper mediated opening of epoxide 5, which in turn would derive from ester 6.
Results and Discussion
Our synthesis of the model compound 2 began with the 1,5-diene 7, prepared in two steps from 2-methylbut-3-en-2-ol. 20, 21 Oxidative cyclisation of diene 7 gave the desired THF diol 6 in good yield (63 %) as a single diastereoisomer. 22 Reduction of ester 6 produced the polar triol 8, which underwent selective tosylation to afford diol 9. Formation of the key epoxide intermediate 5 occurred rapidly when a methylene chloride solution of 9 was treated with DBU. The C3-C13 carbon atoms present in the target were introduced using a copper-catalysed Grignard reaction to give the terminal alkene 3, required for the formation of the butenolide ring in the subsequent step. The Trost ruthenium-catalysed Alder−ene reaction between alkene 3 and optically enriched alkyne 4 ‡ gave the desired diastereoisomeric butenolides 10A and 10B (indistinguishable by nmr) in satisfactory yield in a 5:1 ratio with the uncyclised regioisomer which is typically observed in these reactions. 19 It is noteworthy that the use of protecting groups was avoided during the assembly of the fragments, with both the copper-catalysed Grignard opening of epoxide 5 and the ruthenium-catalysed Alder−ene reaction proceeding in the presence of free hydroxyl groups. With compound 10 in hand, we were in a position to investigate the selective reduction of the disubstituted olefin. The reduction was carried out in a steel bomb at 2−4 atmospheres of H 2 , giving a 3:2 mixture (nmr) of the desired butenolide 2 (two diastereoisomers) and over reduced lactone 13 (possible 4 diastereoisomers) in near quantitative yield. Although efforts to separate 2 and 13 were unsuccessful, we are confident that the over reduction observed here will be avoided when we come to tackle cis-solamin itself by more careful control of H 2 pressure. 23 Unfortunately, we were not able to demonstrate this on the model substrate, as insufficient material was available to attempt the reaction a second time.
In conclusion, a short synthesis to the central THF ring and right hand side-chain of cissolamin has been achieved. In the key step a permanganate oxidative cyclisation of a 1,5-diene was used to generate four of the five stereocentres present in the natural product. The THF diol functionality was shown to be compatible with the organocopper and ruthenium catalysed Alder−ene reactions that will ultimately be used in the synthesis of cis-solamin. An asymmetric synthesis of cis-solamin by this approach is currently under investigation. 
Ethyl (2S*)-2-hydroxy-2-[(2R*,5S*)-5-(1-hydroxy-1-methylethyl)tetrahydro-2-furanyl]ethanoate (6).
A solution of 0.4 M KMnO 4 (6.60 mL, 2.6 mmol, 1.6 eq) and acetic acid (265 µL, 4.6 mmol, 2.8 eq) was added dropwise over 10 min to a mixture of diene 7 (300 mg, 1.7 mmol), buffer (1.16 mL) and acetone (20 mL) at -20 °C (internal). The reaction was quenched after a further 2 min by addition of ice-cooled Na 2 S 2 O 5 (sat. aq, 40 mL) and ice (20 g ). Ether (50 mL), NaCl (10 g) and NaHCO 3 (aq, 20 mL) were added and the organic layer separated. 
(2R*)-2-Hydroxy-2-[(2R*,5S*)-5-(1-hydroxy-1-methylethyl)tetrahydro-2-furanyl]ethyl 1-benzenesulfonate (9).
To a solution of triol 8 (55 mg, 0.29 mmol), tosyl chloride (110 mg, 0.58 mmol) and DMAP (4 mg, 0.03 mmol) in CH 2 Cl 2 (10 mL) was added Et 3 N (0.3 mL, 2 mmol). After 16 h CH 2 Cl 2 (40 mL) and brine (20 mL) were added, the organic phase was separated, dried (Na 2 SO 4 ) and concentrated in vacuo to give a colourless oil (160 mg). Purification by column chromatography using silica gel (3:7 EtOAc/CH 2 Cl 2 ) gave the title compound 9 (69 mg, 0.20 mmol, 68 %) as a colourless oil. 1 
2-(2S*,5R*)-5-[(2R*)Oxiran-2-yl]tetrahydro-2-furanyl-2-propanol (5).
To a solution of tosylate 9 (186 mg, 0.54 mmol) in CH 2 Cl 2 (15 mL) at 0 °C was added DBU (90 mg, 0.59 mmol) dropwise by syringe. The reaction was allowed to warm to rt and stirred for 12 h. Concentration in vacuo gave a yellow oil, which was purified by column chromatography on silica gel (1:40 1R*)-1-[(2R*,5S*)-5-(1-Hydroxy-1-methylethyl)tetrahydro-2-furanyl]-12-tridecen-1-ol (3) . A solution of undec-10-enylmagnesium bromide (11) in THF (3.5 mL of 0.2 M, 0.7 mmol) was added to a suspension of CuI (28 mg, 0.15 mmol) in THF (10 mL) at 0 °C. After 10 min stirring, the solution was cooled to -70 °C (internal) whereupon it went grey. A solution of epoxide 5 (25 mg, 0.14 mmol) in THF (2 mL) was added dropwise. After 45 min the reaction mixture was quenched by the addition of an aqueous solution of saturated NH 4 Cl /NH 4 OH (9:1, 30 mL). Ether (60 mL) was added and the organic phase separated. The organic phase was then washed with brine (20 mL), dried (Na 2 SO 4 ) and concentrated in vacuo to give a yellow oil (250 mg). Purification by column chromatography on silica gel (3:7 EtOAc/hexane) gave the title THF diol 3 (32 mg, 0.10 mmol, 73 %) as a white solid. Recrystallisation from EtOAc/hexane gave white crystals of mp 30-33 °C; In a steel bomb were placed butenolide 10 (30 mg, 0.07 mmol) and Wilkinson's catalyst (7 mg, 0.007 mmol) in a 1:1 solution of benzene/ethanol (3 mL). After 3 cycles of nitrogen/evacuation, H 2 (2-4 bar) was introduced. The mixture was stirred at rt for 18 h. After releasing the pressure, CHCl 3 (10 mL) was added and the mixture filtered, resulting in a brown liquor that was concentrated in vacuo and then purified by column chromatography on silica gel (50 % EtOAc/hexane). This gave a yellow oil that contained butenolide 2 and the over reduced lactone 13 as a 3:2 inseparable mixture (28 mg, 95 %). 
